Masahiro Morimoto

Substitution of an Aspartic Acid Results in Constitutive Activation of c-kitReceptor Tyrosine Kinase in a Rat Tumor Mast Cell Line RBL-2H3

Tohru Tsujimura, T Furitsu, Masahiro Morimoto et al. · International Archives of Allergy and Immunology · 2009 · 126 citations

Life Sciences, Immunology, Molecular Biology +15

Efficacy of treat-and-extend regimen with aflibercept for pachychoroid neovasculopathy and Type 1 neovascular age-related macular degeneration

Hidetaka Matsumoto, Takashi Hiroe, Masahiro Morimoto et al. · Japanese Journal of Ophthalmology · 2018 · 88 citations

Medicine, Ophthalmology, Pharmacotherapy +13

Role of Aspartic Acid 814 in the Function and Expression of c-kit Receptor Tyrosine Kinase

Y Moriyama, Tohru Tsujimura, Koji Hashimoto et al. · Journal of Biological Chemistry · 1996 · 75 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy

Masahiro Morimoto, Hidetaka Matsumoto, Kensuke Mimura et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 2017 · 70 citations

Life Sciences, Pharmacotherapy, Immunotherapy +3

TREAT-AND-EXTEND REGIMEN WITH AFLIBERCEPT FOR RETINAL ANGIOMATOUS PROLIFERATION

Hidetaka Matsumoto, Taku Sato, Masahiro Morimoto et al. · Retina · 2016 · 43 citations

Medicine, Ophthalmology, Pharmacotherapy +17